Clinical trial
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of…
NCT00438178 · Gemin X, Industry · Completed
Key facts
| NCT number | NCT00438178 |
|---|---|
| Title | Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies |
| Official title | A Phase I Study of Obatoclax Mesylate (GX15-070MS) in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myeloid Leukemia (CML)in Myeloid Blast Phase, Myelofibrosis, Previously-Treated Chronic Lymphocytic Leukemia (CLL), or Aplastic Anemia |
| Lead sponsor | Gemin X, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hematological Malignancies |
| Intervention type | Drug |
| Interventions | Obatoclax mesylate (GX15-070MS) |
| Enrollment | 44 |
| Start date | Oct 1, 2005 |
| Primary completion | Oct 1, 2007 |
| First posted | Feb 22, 2007 |
| Last update posted | May 12, 2014 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: